Xenon Pharmaceuticals Inc.
NASDAQ:XENE
45.74 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 148.643 | 57.242 | 175.688 | 45.009 | 24.755 | 67.754 | 20.486 | 17.095 | 58.651 | 72.026 | 37.95 | 60.162 |
| Short Term Investments
| 489.439 | 534.845 | 376.086 | 131.988 | 116.603 | 51.552 | 23.181 | 47.051 | 0 | 12.015 | 11.326 | 0 |
| Cash and Short Term Investments
| 638.082 | 592.087 | 551.774 | 176.997 | 141.358 | 119.306 | 43.667 | 64.146 | 58.651 | 84.041 | 49.276 | 60.162 |
| Net Receivables
| 0.874 | 0.986 | 2.765 | 1.822 | 0.813 | 0.256 | 0.438 | 0.2 | 0.315 | 0.215 | 0.44 | 0.392 |
| Inventory
| 0 | -0.986 | -2.765 | -1.822 | 0 | 0 | 0 | 0 | -0.315 | 0 | 0 | 0 |
| Other Current Assets
| 6.006 | 8.211 | 7.246 | 4.786 | 2.695 | 1.875 | 0.716 | 1.329 | 2.215 | 0.686 | 0.153 | 0.149 |
| Total Current Assets
| 644.962 | 600.298 | 559.02 | 181.783 | 144.866 | 121.437 | 44.821 | 65.675 | 60.866 | 84.942 | 49.869 | 60.703 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 18.846 | 16.906 | 12.522 | 6.88 | 2.593 | 0.991 | 1.07 | 1.404 | 1.989 | 2.476 | 1.879 | 2.602 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 292.792 | 128.682 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0.802 | 0.509 | 0.465 | 0.523 | 0.238 | 0.105 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 7.396 | 7.751 | 0 | 0 | 0 | -0.105 | 0.23 | 0.408 | 1.094 | 0 | 2.739 | -2.602 |
| Total Non-Current Assets
| 319.836 | 153.848 | 12.987 | 7.403 | 2.831 | 0.991 | 1.3 | 1.812 | 3.083 | 2.476 | 4.618 | 2.602 |
| Total Assets
| 964.798 | 754.146 | 572.007 | 189.186 | 147.697 | 122.428 | 46.121 | 67.487 | 63.949 | 87.418 | 54.487 | 63.305 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 8.598 | 8.491 | 3.824 | 3.041 | 2.473 | 0.665 | 1.253 | 1.463 | 1.088 | 0.553 | 0.391 | 0.821 |
| Short Term Debt
| 1.299 | 0.488 | 0.605 | 0.265 | 4.818 | 15.014 | 0.7 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 9.288 | 3.642 | 29.743 | -15.014 | 0 | 0 | 0.157 | 11.622 | 15.92 | 17.015 |
| Other Current Liabilities
| 17.376 | 13.723 | 0.605 | 7.833 | 6.345 | 3.454 | 2.13 | 2.053 | 1.537 | 2.111 | 1.892 | 1.36 |
| Total Current Liabilities
| 27.273 | 22.702 | 14.322 | 14.781 | 43.379 | 4.119 | 4.083 | 3.516 | 2.782 | 14.286 | 18.203 | 19.196 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 9.604 | 9.947 | 7.652 | 3.05 | 11.632 | 15.014 | 6.104 | 0 | 0 | 0 | 0 | 1.665 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0.709 | 0 | 0 | 0 | 0 | 0.157 | 11.886 | 29.637 |
| Deferred Tax Liabilities Non-Current
| 0 | 0.509 | 0 | 0 | 10.889 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | -0.509 | 0 | 0 | -10.889 | 0 | 0 | 0.07 | 0.133 | 0.196 | 0.282 | 0.184 |
| Total Non-Current Liabilities
| 9.604 | 9.947 | 7.652 | 3.05 | 12.341 | 15.014 | 6.104 | 0.07 | 0.133 | 0.353 | 12.168 | 31.486 |
| Total Liabilities
| 36.877 | 32.649 | 21.974 | 17.831 | 55.72 | 19.133 | 10.187 | 3.586 | 2.915 | 14.639 | 30.371 | 50.682 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 7.732 | 7.732 | 7.732 | 7.732 | 173.841 | 173.246 | 148.634 | 0 | 102.488 | 102.488 |
| Common Stock
| 1,436.374 | 1,065.136 | 783.17 | 397.748 | 294.244 | 265.923 | 173.841 | 173.246 | 148.634 | 147.157 | 6.147 | 6.008 |
| Retained Earnings
| -665.14 | -482.747 | -357.374 | -278.492 | -249.655 | -207.885 | -173.388 | -142.681 | -119.693 | -103.734 | -116.752 | -128.784 |
| Accumulated Other Comprehensive Income/Loss
| -0.077 | -3 | -0.99 | -0.99 | -0.99 | -0.99 | -0.99 | -0.99 | -0.99 | -0.99 | 2.511 | 3.747 |
| Other Total Stockholders Equity
| 156.764 | 142.108 | 117.495 | 45.357 | 40.646 | 38.515 | -137.37 | -138.92 | -115.551 | 30.346 | 29.722 | 29.164 |
| Total Shareholders Equity
| 927.921 | 721.497 | 550.033 | 171.355 | 91.977 | 103.295 | 35.934 | 63.901 | 61.034 | 72.779 | 24.116 | 12.623 |
| Total Equity
| 927.921 | 721.497 | 550.033 | 171.355 | 91.977 | 103.295 | 35.934 | 63.901 | 61.034 | 72.779 | 24.116 | 12.623 |
| Total Liabilities & Shareholders Equity
| 964.798 | 754.146 | 572.007 | 189.186 | 147.697 | 122.428 | 46.121 | 67.487 | 63.949 | 87.418 | 54.487 | 63.305 |